When administered to mice, the complex inhibited tumor growth, reduced signs of general toxicity, neurotoxicity and cardiotoxicity, increased the immune response (serum levels of IFN-γ, TNF-α and chemokines CCL4 and CCL17) and prolonged animal survival. The gene discussed is CCL17; the disease is neoplasm.